Mumps vaccine is the best way to prevent mumps. This vaccine is included in the combination measles-mumps-rubella (MMR) and measles-mumps-rubella-varicella (MMRV) vaccines. Two doses of mumps vaccine are 88% (range: 66-95%) effective at preventing the disease; one dose is 78% (range: 49%−92%) effective. The first vaccine against mumps was licensed in the United States in 1967, and by 2005, high two-dose childhood vaccination coverage reduced disease rates by 99%.
Children should receive the first dose of mumps-containing vaccine at 12-15 months and the second dose at 4-6 years. All adults born during or after 1957 should have documentation of one dose. Adults at higher risk, such as university students, health care personnel, and international travelers, and persons with potential mumps outbreak exposure should have documentation of two doses of mumps vaccine or other proof of immunity to mumps.
Recommendations and other useful information about mumps vaccination.
Mumps references and resources, provider education tools, and materials for patients.
- Clinical Vaccine Information on Mumps
- Vaccine Recommendations
- Healthcare Worker Vaccination
- References & Resources
- Provider Education
- Materials for Patients
- Vaccine Questions
Mumps: Questions and Answers [4 pages]
Ready-to-print version of one of the CDC-reviewed Q&A materials located on Immunization Action Coalition's website (www.vaccineinformation.org).
- Page last reviewed: May 22, 2012
- Page last updated: July 2, 2012
- Content source: